Nirav N. Shah, MD¹, Fateeha Furqan, MD², Aniko Szabo, PhD^3*, Jessica Neumann^2*, Parameswaran Hari, MD, MRCP⁴, Dina Schneider^5*, Bryon Johnson, PhD¹, Mehdi Hamadani, MD¹ and Timothy S. Fenske, MD²

¹Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
³Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
⁴Medical College of Wisconsin, Milwaukee, WI
⁵A Miltenyi Biotec Company, Lentigen Technology Inc., Gaithersburg, MD

Javier Munoz, MD, MS, MBA¹, Patrick M. Reagan, MD², Andre H. Goy, MD, MS^3*, David B. Miklos, MD, PhD⁴, Dan Zheng, PhD^5*, Xiang Fang, PhD^5*, Rhine R. Shen, PhD^5*, Rubina Siddiqi, PhD, MBA^5*, Ioana Kloos, MD, FRCPC^5*, Marie José Kersten, MD, PhD⁶ and Michael Wang, MD⁷

¹Banner MD Anderson Cancer Center, Gilbert, AZ
²University of Rochester School of Medicine, Rochester, NY
³John Theurer Cancer Center, Hackensack, NJ
⁴Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁵Kite, a Gilead Company, Santa Monica, CA
⁶on behalf of HOVON/LLPC, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
⁷University of Texas MD Anderson Cancer Center, Houston, TX

Yuankai Shi^1*, Yongping Song, M.D., Ph.D.^2*, Mingzhi Zhang, MD, PhD³, Hongmei Jing⁴, Zhen Wang^5*, Zhiming Li^6*, Junyuan Qi^7*, Fei Li^8*, Wenyu Li⁹, Jianliang Yang^1*, Siman Gao^10*, Huizi Ma^10*, Heming He^10*, Qiying Lu^10* and Wenzhi Tian^10*

¹Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
²Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
³Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁴Department of Hematology, Peking University Third Hospital, Beijing, China
⁵Department of Hematology, Linyi Cancer Hospital, Linyi, China
⁶Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁸Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁹Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
¹⁰ImmuneOnco Biopharmaceuticals(Shanghai) Inc., Shanghai, China

Jacob D. Soumerai, MD¹, Masa Lasica^2*, Stephen Opat^3,4, Chan Y. Cheah^5,6,7, Henry Chan⁸, Emma Verner^9,10*, Eva González Barca^11*, Alessandra Tedeschi^12*, James Hilger^13*, Yiqian Fang^13*, David Simpson^13* and Constantine S. Tam^14,15*

¹Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
²St Vincent’s Hospital Melbourne, Fitzroy, VIC, Australia
³Monash Health, Clayton, VIC, Australia
⁴Monash University, Clayton, VIC, Australia
⁵Medical School, University of Western Australia, Crawley, Australia
⁶Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia
⁷Linear Clinical Research, Nedlands, Australia
⁸North Shore Hospital, Auckland, New Zealand
⁹Concord Repatriation General Hospital, Concord, NSW, Australia
¹⁰University of Sydney, Sydney, NSW, Australia
¹¹Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de-Barcelona, Barcelona, Spain
¹²ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
¹³BeiGene (Shanghai) Co., Ltd., Shanghai, China and BeiGene USA, Inc., San Mateo, CA
¹⁴Monash University, Melbourne, VIC, Australia
¹⁵Alfred Hospital, Melbourne, VIC, Australia

Juan-Manuel Sancho, MD, PhD^1*, Pau Abrisqueta, MD, PhD^2*, Abhijeet Kumar, MD³, Raul Cordoba, MD, PhD⁴, Monica Tani, MD^5*, Teng Liu, PhD^6*, Erica Rappold, BSN^6*, Peter Langmuir, MD^6* and Armando Lopez-Guillermo, MD⁷

¹Clinical Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Barcelona, Spain
²Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
³University of Arizona, Tucson, AZ
⁴Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
⁵Haematology Unit Santa Maria delle Croci Hospital, Ravenna, Italy
⁶Incyte Corporation, Wilmington, DE
⁷Clinic Barcelona, Barcelona, Spain

Sikander Ailawadhi¹, Ricardo D Parrondo, MD², Betsy Laplant, MS^3*, Victoria R. Alegria^4*, Jamie B Elliott^5*, Ashley Zimmerman^6*, Keisha Heslop^5*, Dustin Chapin^7*, Taimur Sher, MD², Vivek Roy, MD⁴, Ahsan Rasheed^4*, Aneel Paulus, MD¹ and Asher Chanan-Khan, MD⁸

¹Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
⁵Department of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁶Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁷Mayo Clinic, Jacksonville, FL
⁸Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL

Chakra P Chaulagain, MD, FACP¹, Kevin Landau, MD^2*, Hong Liang, PhD^2* and Chieh-Lin Fu, MD³

¹Department of Hematology and Oncology, Cleveland Clinic Florida, Maroone Cancer Center, Weston, FL
²Cleveland Clinic Flroida, Weston, FL
³Department of Hematology and Oncology, Maroone Cancer Center, Cleveland Clinic Flroida, Weston, FL

Alba Cabirta^1*, Pau Abrisqueta, MD, PhD^2*, Víctor Navarro Garcés^3*, Marta Canelo-Vilaseca, MD^4*, Marina Gomez-Rosa, MD^5*, Alberto Lopez García, MD^6*, Tomas García, MD, PhD^7*, Fatima De la Cruz, MD^8*, Juan-Manuel Sancho, MD, PhD^9*, Eduardo Rios Herranz, MD^10*, Raul Cordoba, MD, PhD¹¹, Angel Serna, MD^12*, Moraima Jiménez, MD^13*, Sabela Bobillo, MD, PhD^1*, Marta Julia, MD^1*, Cecilia Carpio, MD^14*, Gloria Iacoboni, MD^15*, Laura Gallur, MD^16*, Josep Castellvi, MD^17*, Francesc Bosch, MD, PhD¹⁸ and Ana Marin-Niebla, MD, PhD^1*

¹Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
²Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
³Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain
⁴Hematology Department, Institut Català d’Oncologia-University Hospital Germans Trias i Pujol, Barcelona, Spain
⁵Hematology Department, University Hospital Ntra. Sra de Valme, Sevilla, Spain
⁶Fundación Jimenez Díaz University Hospital, Madrid, Spain
⁷Hospital Arnau de Vilanova, Lleida, Spain
⁸Hematology Department, University Hospital Virgen del Rocío, Sevilla, Spain
⁹Clinical Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Hospital Universitario Virgen de Valme, Sevilla, Spain
¹¹Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
¹²Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹³Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
¹⁴Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Hospital Universitario Vall d'Hebrón, Barcelona, Spain
¹⁵Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, WA, Spain
¹⁶Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
¹⁷Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Please Select, Spain
¹⁸Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Lorenzo Falchi, MD¹, Franck Morschhauser, MD, PhD^2*, John G. Gribben, MD, DSc, FRCPath³, Huiqiang Huang, MD, PhD^4*, Minh Dinh, MD^5*, Rebekah Conlon^5*, Xiaorong Chen^5*, Brian Elliot, MD^6* and John F. Seymour, MBBS, PhD, FRACP⁷

¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Hematology Department, Lille University Hospital, Lille, France
³Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁴Sun Yat-sen University, Guangzhou, China
⁵AbbVie, Inc., North Chicago, IL
⁶Genmab, Princeton, NJ
⁷Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Australia

Juan Pablo Alderuccio, MD¹, Isildinha M Reis, PhD^2*, Jean L. Koff, MD, MSc³, Melissa C. Larson, MS^4*, Dai Chihara, MD⁵, Wei Zhao, MD, MS^6*, Sara Haddadi^7*, Thomas M. Habermann, MD⁸, Peter Martin, FRCPC, MD, MS⁹, Jennifer R Chapman-Fredricks, MD^10*, Christopher Strouse, MD¹¹, Brad S. Kahl, MD¹², Jonathon B. Cohen, MD, MS¹³, Jonathan W. Friedberg, MD, MMSc¹⁴, James R. Cerhan, MD, PhD⁴, Christopher R. Flowers, MD¹⁵ and Izidore S. Lossos, MD¹⁶

¹Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
²Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
³Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁴Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
⁷Sylvester Comprehensive Cancer Center, Miami
⁸Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁹Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
¹⁰/Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
¹¹Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹²Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
¹³Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹⁴James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
¹⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁶Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL

Jose Tomas Navarro, MD, PhD^1*, Carolina Celades^2,3*, Andrea Usas^2,3*, Olga García^4*, Eva Gonzalez Barca, MD, PhD^5*, Fina Climent, PhD^6*, Andrea Feu^7*, Ana Isabel Jiminez Ubieto, MD, PhD^8*, Alba Gutiérrez de la Peña^9*, Mariana Bastos-Oreiro, MD, PhD^10,11*, Teresa Aldamiz-Echevarría, MD^12*, Antonio Gutierrez, MD, PhD^13*, Leyre Bento De Miguel^14*, Pau Abrisqueta Costa, MD, PhD^15*, Carmen Alonso Prieto^16*, Christian David Tejada Chaves, MD^16*, Enrique M. Ocio^17,18, Noemi Fernandez-Escalada, MD^19*, Belén Navarro, MD^20*, José Miguel Mateos Pérez, MD^21*, Andrea Rivero, MD^22*, Carlos Fernández De Larrea, MD, PhD^23*, Alberto Lopez-Garcia^24*, Paola Sandra Villafuerte Gutierrez, MD^25*, Sergio Felipe Pinzón^26*, Elena Pérez Ceballos^27*, Andrés González^28*, José Ángel Hernández-Rivas^29,30*, Raquel Del Campo^31*, Emilia Pardal, MD^32*, Ramon Garcia-Sanz^33,34, Jordina Rovira Sole^35*, Juan-Manuel Sancho, MD, PhD^36* and Gustavo Tapia, MD, Prof.^37*

¹Hematology, Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
²Josep Carreras Leukaemia Research Institute, Lymphoid Neoplasms, Badalona, Spain
³Medicine, Universitat Autònoma de Barcelona, Badalona, Spain
⁴Hematology Department, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, PETHEMA Group, Barcelona, Spain
⁵Institut Catalá d’Oncologia Hospitalet, Universitat de Barcelona, Barcelona, Spain
⁶Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Spain
⁷Pathology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Hospitales de Llobregat, Spain
⁸Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁹Hematology, Hospital 12 de Octubre, Madrid, Spain
¹⁰Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
¹¹Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
¹²Department of Hematology, Hospital Universitario Gregorio Marañón, Instituto de investigación Sanitaria Gregorio Marañón, Madrid, Spain
¹³Hematology Department, Hospital Universitario Son Dureta, Palma, Spain
¹⁴Department of Hematology, Hospital Universitari Son Espases / IdISBa, Palma De Mallorca, Spain
¹⁵Department of Hematology, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹⁶Hematology and Hemotherapy, Hospital Arnau de Vilanova, Valencia, Spain
¹⁷University of Cantabria, Santander, Spain
¹⁸Hematology, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁹Hospital Universitario Marqués de Valdecilla, Santander, Spain
²⁰Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
²¹Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain
²²Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain
²³Department of Hematology, IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
²⁴Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
²⁵Hematology and hemotherapy department, Hospital Universitario Príncipe de Asturias, Alcala De Henares, Spain
²⁶Hematology, Hospital del Mar, Barcelona, Spain
²⁷Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain
²⁸Systemic Autoimmune Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain
²⁹Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
³⁰Medicine Department, Universidad Complutense de Madrid, Madrid, Spain
³¹Hematology Department, Hospital Son Llàtzer, Palma, Spain
³²Hematology and Hemotherapy, Hospital Virgen del Puerto, Plasencia, Spain
³³Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
³⁴Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
³⁵Institut Catala d’Oncologia. Hospital Joan XXIII, Tarragona, AL, ESP
³⁶Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
³⁷Department of Pathology, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain

Ilja Kalashnikov, MD^1*, Tomas Tanskanen, MD, PhD^2*, Leevi Viisanen, MD^1*, Nea Malila, MD, PhD^2*, Sirkku Jyrkkio, MD, PhD^3* and Sirpa Leppä, MD, PhD¹

¹University of Helsinki and Helsinki University Hospital, Helsinki, Finland
²Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland
³Turku University Hospital, Turku, Finland

Teresa Villalobos, MD^1*, Ana Muntañola Prat, MD^2*, Sonia González de Villambrosia, MD^3*, Maria J. Rodriguez-Salazar, MD^4*, Ana Isabel Jiminez Ubieto, MD, PhD^5*, Gabriela Bastidas-Mora^6*, Raul Cordoba, MD, PhD⁷, Maria Stefania Infante^8*, Maria Jesus Vidal, MD^9*, Francisco Javier Diaz-Galvez^10*, Monica Baile^11*, Mariana Bastos-Oreiro, MD, PhD^12,13*, Carlos Panizo^14*, Juan-Manuel Sancho, MD, PhD^15*, Belen Navarro Matilla^16*, Tomas García, MD, PhD^17*, Lourdes Escoda, MD^18*, Pau Abrisqueta, MD, PhD^19*, María José Terol, MD PhD^20*, Raquel Del Campo^21*, Armando López-Guillermo, MD, PhD^22*, Antonio Salar^23* and Carlos Montalban, MD, PhD^24*

¹Hematology, Hospital Universitari Mutua Terrassa, Terrassa, Spain
²Hospital Universitari Mutua Terrassa, Barcelona, Spain
³Hospital Universitario Marqués de Valdecilla, Santander, Spain
⁴Hematology Department, Hospital General Universitario de Canarias, Santa Cruz de Tenerife, Spain
⁵Hospital 12 de Octubre, Madrid, Spain
⁶Hospital Sagrat Cor, Barcelona, Spain
⁷Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain
⁸Hospital Infanta Leonor, Madrid, Spain
⁹Department of Hematology, Hospital Universitario de Leon, Leon, Spain
¹⁰Hospital Universitario de Burgos, Burgos, Spain
¹¹Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain
¹²Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
¹³Hospital General Universitario Gregorio Marañón (IiSGM), Madrid, Spain
¹⁴Clínica Universidad de Navarra, Pamplona, Spain
¹⁵Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
¹⁶Hospital Puerta de Hierro, Madrid, Spain
¹⁷Hospital Arnau de Vilanova, Lleida, Spain
¹⁸Hematology Department, ICO - Hospital Joan XXIII, Tarragona, Spain
¹⁹Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain
²⁰Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
²¹Hematology Department, Hospital Son Llàtzer, Palma, Spain
²²Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain
²³Hospital del Mar, Barcelona, Spain
²⁴Hematology, MD Anderson Cancer Center, Madrid, Spain

Angel Serna, MD^1*, Angela Sanchez^1*, Laia Lopez^2*, Juan-Manuel Sancho, MD, PhD^3*, Eva Gonzalez Barca, MD, PhD^4*, Alberto Lopez-Garcia^5*, Raul Cordoba, MD, PhD⁶, Adolfo Jesús Sáez Marín, MD^7*, Ana Isabel Jiminez Ubieto, MD, PhD^8*, Ainara Ferrero^9*, Tomas García, MD, PhD^10*, Alba Cabirta^1*, M Moraima Jimenez, MD^11*, Lucia Martin, MD^11*, Marta Julia, MD^11*, Sabela Bobillo, MD, PhD^11*, Ana Marin-Niebla, MD, PhD^11*, Francesc Bosch, MD, PhD¹² and Pau Abrisqueta, MD, PhD^13*

¹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
²Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain, Barcelona, Spain
³Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
⁴Department of Hematology, Institut Catalá d’Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
⁵Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁶Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain
⁷Servicio de Hematología, Hospital 12 de Octubre, Madrid, Madrid, Spain
⁸Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Hospital Universitario 12 de Octubre, Complutense University, CNIO, Madrid, MADRID, Spain
⁹Hematology Department, University Hospital Arnau de Vilanova, Lleida, Lleida, Spain
¹⁰Hospital Arnau de Vilanova, Lleida, Spain
¹¹Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
¹²Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹³Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain

Zheng Weiwei^1*, Zhou Hui^2*, Xi Zhang, M.D., Ph.D.^3*, Jing Hongmei^4*, Zhou Dongmei^5*, Zhou Fang^2*, Gao Li^6*, Wan Wei^7*, Song Yaobo^5*, Haung Yan, PhD^8*, Xu Linfeng^9*, Hu Yonghan^9*, Le Meijie^9*, Qi Junyuan^1* and Lugui Qiu¹⁰

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China, tianjin, China
²Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China, changsha, China
³Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
⁴Peking University Third Hospital, Beijing, China
⁵Department of Medical Oncology Ward, Yantaishan Hospital, Yantai, China, yantai, China
⁶Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China, chongqing, China
⁷Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
⁸Evopoint Biosciences Co., Ltd., Suzhou, China, Shanghai, AL, China
⁹Evopoint Biosciences Co., Ltd., Suzhou, China, suzhou, China
¹⁰State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Qingqing Cai, PhD¹, Yi Xia, MD, PhD^2*, Panpan Liu, MD, PhD^1*, Yuchen Zhang, BMBS^1*, Huiqiang Huang, MD, PhD², Yan Gao^3*, Guowei Li, MD, PhD^4*, Xiuhua Sun, MD, PhD^5* and Xueyi Pan, MD, PhD^6*

¹Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
³Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, NY, China
⁴Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, China
⁵Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China
⁶Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Mayur Narkhede, MBBS^1,2, Lauren Shea^3*, Gaurav Goyal, MD¹ and Amitkumar Mehta, MD¹

¹Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
²O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL
³University of Alabama At Birmingham, Birmingham, AL

Nilesh Kapoor, BA¹, Qiuhong Zhao, MS^2*, Andrew Stiff, MD, PhD², Seema A. Bhat, MD², Mirela Iulia Anghelina, MD, MPH^2*, Jasmine Neal, MPH^2*, Leslie A. Andritsos, MD³, James S. Blachly, MD², Narendranath Epperla, MD, MS², Zeinab El Boghdadly, MBBCh^4*, Michael R. Grever, MD² and Kerry A. Rogers, MD²

¹College of Medicine, The Ohio State University, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
⁴Division of Infectious Disease, Department of Internal Medicine, The Ohio State University, Columbus, OH

Karan Chohan^1*, Saurabh Zanwar², Ronald Go, MD², Jonas Paludo, MD², Carrie A. Thompson, MD², Asher Chanan-Khan, MD³, Sikander Ailawadhi³, Thomas M. Habermann, MD², Thomas E. Witzig, MD², Morie A Gertz, MD², Stephen M. Ansell, MD, PhD², Shaji K Kumar, MD², Rajiv K. Pruthi, M.B.B.S², William L. Nichols, MD², Prashant Kapoor, MD², Meera Sridharan, MD, PhD² and Jithma P. Abeykoon, MD²

¹Department of Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Jacksonville, FL

Farheen Mir, MBBS FRCPath^1*, Anna Robinson, MBBS^2*, Mark Edward Ethell, MD^3*, Michael Potter, MD⁴, Emma Nicholson, MD, PhD^5*, Chloe Anthias^2*, Sandra Easdale^2*, Carlos Gonzalez-Arias^2*, Amit Sud, MD, PhD, FRCPath, MRCP², Claire E. Dearden, MD, FRCP, FRCPath^6*, Ian Chau, MD^7*, David Cunningham, MD, FRCP, FMedSci^8*, Dima El-Sharkawi, MBBS, FRCPath, PhD^9*, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR^7* and Sunil Iyengar^10*

¹Royal Marsden Hospital, Sutton, ENG, GBR
²Royal Marsden Hospital, Sutton, United Kingdom
³Royal Marsden Hospital, Sutton, ENG, United Kingdom
⁴Royal Marsden Hospital, Sutton, GBR
⁵The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
⁶Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁸Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom
⁹The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom
¹⁰Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom

Michael L. Wang, MD¹, Nirav N. Shah, MD², Wojciech Jurczak, MD, PhD^3*, Pier Luigi Zinzani, MD, PhD⁴, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD^5*, Chan Yoon Y. Cheah, MD⁶, Chaitra S. Ujjani, MD⁷, Youngil Koh, MD, PhD⁸, Koji Izutsu^9*, James N. Gerson, MD¹⁰, Ian W. Flinn, MD PhD¹¹, Benoit Tessoulin, MD^12*, Alvaro J. Alencar, MD¹³, Shuo Ma, MD¹⁴, Ewa Lech-Marańda, MD, PhD^15*, Joanna M. Rhodes, MD, MSCE¹⁶, Krish Patel, MD¹⁷, Jennifer A. Woyach, MD¹⁸, Nicole Lamanna, MD¹⁹, Yucai Wang, MD, PhD²⁰, Constantine S. Tam^21*, John F. Seymour, MBBS, PhD, FRACP²¹, Talha Munir, MBBS, MRCP, FRCPath, PhD^22*, Hirokazu Nagai, MD, PhD²³, Francisco Hernandez-Ilizaliturri, MD²⁴, Anita Kumar, MD²⁵, Andrew D. Zelenetz, MD, PhD²⁵, Preetesh Jain, MBBS, MD, DM, PhD²⁶, Binoj Nair, PhD^27*, Donald E. Tsai, MD, PhD^27*, Minna Balbas, PhD^27*, Richard A. Walgren, MD, PhD²⁷, Paolo B. Abada, MD, PhD^27*, Chunxiao Wang, PhD^28*, Junjie Zhao, PhD^27* and Anthony R. Mato, MD, MSCE²⁵

¹MD Anderson Cancer Center, Houston, TX
²Medical College of Wisconsin, Brookfield, WI
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁴Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
⁵Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁶Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
⁷Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁸Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁹National Cancer Center Hospital, Tokyo, Japan
¹⁰Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
¹¹Sarah Cannon Research Institute, Nashville, TN
¹²Hematology Department, Nantes University Hospital, Nantes, France
¹³Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
¹⁴Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁵Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁶Northwell Health Cancer Institute, New Hyde Park, NY
¹⁷Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
¹⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁹New York-Presbyterian/ Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY
²⁰Division of Hematology, Mayo Clinic, Rochester, MN
²¹Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
²²Department of Haematology, St James’s University Hospital, Leeds, United Kingdom
²³Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
²⁴Roswell Park Cancer Institute, Buffalo, NY
²⁵Memorial Sloan Kettering Cancer Center, New York, NY
²⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁷Loxo@Lilly, Indianapolis, IN
²⁸Eli Lilly and Company, Indianapolis, IN

Irl Brian Greenwell, MD¹, Jeffrey M. Switchenko, PhD, MS^2*, Alexander F. M. Craig, MD, MPhil³, Ash A. Alizadeh, MD, PhD⁴, Pamela B. Allen, MD⁵, Alicia Escobar^6*, Kelly Valla, PharmD^7*, Aseala Abousaud, PharmD^8*, Priya Parikh^6*, Danielle Roberts, PA-C^9*, Jessica J. Neely, PA-C^6*, Alexandra Palmer, NP-C^10*, Kristie A. Blum, MD⁹, Jonathon B. Cohen, MD, MS¹¹ and Marcela Algave^12*

¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²Departments of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA
³Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
⁴Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA
⁵Department of Hematology, Emory University School of Medicine, Decatur, GA
⁶Emory University, Atlanta, GA
⁷Winship Cancer Institute, Emory University Hospital, Atlanta, GA
⁸Emory Healthcare, Atlanta, GA
⁹Winship Cancer Institute, Emory University, Atlanta, GA
¹⁰Winship Cancer Institute, Emroy University, Atlanta, GA
¹¹Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹²Emory University, Atlanta

Francesca Cordero^1*, Simone Ferrero, MD^2,3, Simone Pernice^1*, Elisa Genuardi^3*, Roberta Sirovich^4*, Beatrice Alessandria^3*, Andrea Evangelista^5*, Simone Ragaini^2,3*, Maurizio Martelli, MD^6*, Alice Di Rocco, MD^6*, Alessandro Re, MD^7*, Chiara Pagani, MD^8*, Vittorio Stefoni, MD^9*, Federica Cavallo, MD^2,3*, Carola Boccomini^10*, Monica Balzarotti, MD^11*, Vittorio Ruggero Zilioli, MD^12*, Maria Gomes da Silva^13*, Luca Arcaini^14*, Melania Celli^15*, Gian Maria Zaccaria^16*, Dora Tortarolo^1*, Sergio Cortelazzo^17* and Marco Ladetto¹⁸

¹Department of Computer Science, University of Torino, Torino, Italy
²Division of Hematology , AOU Città della Salute e della Scienza di Torino, Torino, Italy
³Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
⁴Department of Mathematics G. Peano, University of Torino, Torino, Italy
⁵Unit of Cancer Epidemiology, CPO Piemonte, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
⁶Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
⁷Hematology Division, ASST-Spedali Civili di Brescia, Brescia, Italy
⁸Department of Hematology, ASST Spedali Civili, Brescia, Italy
⁹Hematology, Department of Translational and Precision Medicine, Università di Bologna, Bologna, Italy
¹⁰Division of Hematology 2, AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹¹Unit of Hematology, Humanitas Clinical and Research Center, Rozzano, Italy
¹²Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹³Division of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
¹⁴Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁵U.O. di Ematologia, Ospedale degli Infermi di Rimini, Rimini, Italy
¹⁶Hematology and Cell Therapy Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
¹⁷Oncology unit, Clinica Humanitas/Gavazzeni, Bergamo, Italy
¹⁸Division of Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Sheila K Pierson, MSc^1*, Mateo Sarmiento Bustamante^1*, Joshua D Brandstadter, MD, PhD, MSc², Daisy Alapat^3*, Adam Bagg, MD⁴, Mary Jo Lechowicz, MD⁵, Gordan Srkalovic, MD, PhD⁶, Megan S. Lim, MD, PhD⁷, Frits van Rhee⁸ and David C Fajgenbaum, MD, MBA, MSc¹

¹Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, SWARTHMORE, PA
³UAMS, Little Rock, AR
⁴Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
⁵Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
⁶Sparrow Herbert-Herman Cancer Center, Lansing, MI
⁷Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁸Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR

Robert Stuver, MD¹, Esther Drill, DrPH^2*, David Qualls, MD³, Michelle Okwali, MPH^1*, Connie Lee Batlevi, MD, PhD⁴, Philip C Caron, MD, PhD¹, Zachary D. Epstein-Peterson, MD¹, Lorenzo Falchi, MD¹, Audrey Hamilton, MD^1*, Paul A. Hamlin, MD¹, Steven M. Horwitz, MD¹, Andrew M. Intlekofer, MD, DPhil¹, William T. Johnson, DO¹, Niloufer Khan, MD¹, Oscar B Lahoud, MD⁵, Jennifer Kimberly Lue, MD¹, Matthew J. Matasar, MD, MS⁶, Alison J. Moskowitz, MD¹, Ariela Noy, MD¹, M.Lia Palomba, MD⁷, Santosha Vardhana, MD, PhD¹, Andrew D. Zelenetz, MD, PhD¹, Gilles Salles, MD, PhD¹ and David J. Straus, MD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, Brookline, MA
⁴Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Neil L Berinstein, MD¹, Gail Klein, MSc^2*, Katerina Welsh^3*, Rebecca McClure, MD⁴, Nicholas Allen Forward, MD, MSc, FRCPC⁵, Mona Shafey, MD⁶, Anna Nikonova, MD⁷, David MacDonald, MD⁸, Diego Villa, MD⁹, Irwindeep Sandhu^10*, Mohammed A Aljama, MBBS, FRCPC¹¹ and Jean-François Larouche, MD¹²

¹Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto, ON, CAN
²Centre for Clinical Trial Support, Sunnybrook Research Institute, Toronto, ON, Canada
³Sunnybrook Research Institute, Toronto, ON, Canada
⁴Health Sciences North, Sudbury, ON, Canada
⁵Hematology, Nova Scotia Health Authority/ Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁶Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
⁷McGill University Health Centre, Montreal, QC, Canada
⁸The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
⁹British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰Cross Cancer Centre, Edmonton, AB, Canada
¹¹Division of Hematology, Juravinski Cancer Centre, Hamilton, ON, Canada
¹²CHU de Québec – university Laval, Québec, QC, Canada

Tareq Abuasab, MD¹, Fadi Haddad, MD^1*, Shehab Fareed Mohamed, MD^1*, Jeffrey L. Jorgensen, MD, PhD^2*, Sa A Wang, MD^2*, Philip A. Thompson, MBBS¹, Tapan M. Kadia, MD¹, Yesid Alvarado, MD¹, Sherry A. Pierce, BSN, BA^1*, Michael J. Keating, MBBS³, David McCue^4*, Hagop Kantarjian, MD⁵ and Farhad Ravandi, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴UT MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX